AAAAAA
Results:
1-13
|
Results: 13
Authors:
Tincani, A
Allegri, F
Sanmarco, M
Cinquini, M
Taglietti, M
Balestrieri, G
Koike, T
Ichikawa, K
Meroni, P
Boffa, MC
Citation: A. Tincani et al., Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations - A cooperative project of the European Antiphospholipid Forum, THROMB HAEM, 86(2), 2001, pp. 575-583
Authors:
Nicoletti, F
Di Marco, R
Sacerdote, P
Meroni, P
Mangano, K
Edwards, C
Bartorelli, A
Bendtzen, K
Panerai, A
Citation: F. Nicoletti et al., Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14, ANTIM AG CH, 45(5), 2001, pp. 1591-1594
Authors:
Cimaz, R
Catelli, L
Luzzana, C
Panzeri, P
Meroni, P
Citation: R. Cimaz et al., Neonatal lupus syndromes, ISR MED ASS, 2(3), 2000, pp. 228-231
Authors:
Nicoletti, F
Zaccone, P
Xiang, M
Magro, G
Di Mauro, M
Di Marco, R
Garotta, G
Meroni, P
Citation: F. Nicoletti et al., Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: Exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein, CYTOKINE, 12(4), 2000, pp. 315-323
Authors:
Tincani, A
Balestrieri, G
Allegri, F
Cinquini, M
Vianelli, M
Taglietti, M
Sanmarco, M
Ichikawa, K
Koike, T
Meroni, P
Boffa, MC
Citation: A. Tincani et al., Overview on anticardiolipin ELISA standardization, J AUTOIMMUN, 15(2), 2000, pp. 195-197
Authors:
Nicoletti, F
Di Marco, R
Patti, F
Nicoletti, A
Leonardi, C
Reggio, E
Meroni, P
Reggio, A
Citation: F. Nicoletti et al., The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta 1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cells, AUTOIMMUN, 32(4), 2000, pp. 265-270
Authors:
Nicoletti, F
Di Marco, R
Zaccone, P
Salvaggio, A
Magro, G
Bendtzen, K
Meroni, P
Citation: F. Nicoletti et al., Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism, HEPATOLOGY, 32(4), 2000, pp. 728-733
Authors:
George, J
Meroni, P
Gilburd, B
Raschi, E
Harats, D
Shoenfeld, Y
Citation: J. George et al., Anti-endothelial cell antibodies in patients with coronary atherosclerosis, IMMUNOL LET, 73(1), 2000, pp. 23-27
Authors:
Nicoletti, F
Di Marco, R
Zaccone, P
Xiang, M
Magro, G
Grasso, S
Morrone, S
Santoni, A
Shoenfeld, Y
Garotta, G
Meroni, P
Citation: F. Nicoletti et al., Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr/lpr mice, EUR J IMMUN, 30(2), 2000, pp. 438-447
Authors:
Brucato, A
Cimaz, R
Catelli, L
Meroni, P
Citation: A. Brucato et al., Anti-re-associated sinus bradycardia in newborns, CIRCULATION, 102(11), 2000, pp. E88-E88
Authors:
Di Marco, R
Xiang, M
Zaccone, P
Leonardi, C
Franco, S
Meroni, P
Nicoletti, F
Citation: R. Di Marco et al., Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency, AUTOIMMUN, 31(2), 1999, pp. 75-83
Authors:
Nicoletti, F
Zaccone, P
Conget, I
Gomis, R
Moller, C
Meroni, P
Bendtzen, K
Trepicchio, W
Sandler, S
Citation: F. Nicoletti et al., Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice, DIABETES, 48(12), 1999, pp. 2333-2339
Authors:
Tincani, A
Balestrieri, G
Spatola, L
Meroni, P
Sabbadini, MG
Roubey, RAS
Citation: A. Tincani et al., beta(2)-glycoprotein I and the antiphospholipid syndrome: In vitro and in vivo studies, DECADE OF AUTOIMMUNITY, 1999, pp. 67-74
Risultati:
1-13
|